Climb Bio director granted 40,000 stock options
Climb Bio, Inc. director Alexander Cumbo reported a grant of stock options covering 40,000 shares of common stock.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Climb Bio, Inc. director Alexander Cumbo reported a grant of stock options covering 40,000 shares of common stock. The options have an exercise price of $10.55 per share, expire on June 4, 2036, and vest on the earlier of June 5, 2027 or immediately before the next annual stockholder meeting, subject to continued service.
Insider Trade Summary
Grant/Award: 40,000 shares
Grant/Award
1 txn
Insider
Cumbo Alexander
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 40,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 40,000 contracts (Direct)
Footnotes (1)
- F1. The shares subject to the option will vest on the earlier of June 5, 2027 or the date immediately prior to the date of the next annual meeting of stockholders, subject to the reporting person's continued service through such date.
Key Figures
Option grant size: 40,000 options
Exercise price: $10.55 per share
Total options after grant: 40,000 options
+2 more
5 metrics
Option grant size
40,000 options
Stock Option (Right to Buy) granted to director
Exercise price
$10.55 per share
Strike price for Climb Bio common stock options
Total options after grant
40,000 options
Holdings following reported transaction
Option expiration date
June 4, 2036
Expiration of granted stock options
Vesting date benchmark
June 5, 2027
Latest vesting date, or earlier before next annual meeting
Key Terms
Stock Option (Right to Buy), Common Stock, exercise price, vest, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
Common Stock financial
"underlying_security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
exercise price financial
"conversion_or_exercise_price: "10.5500""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest financial
"The shares subject to the option will vest on the earlier of June 5, 2027"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
annual meeting of stockholders financial
"or the date immediately prior to the date of the next annual meeting of stockholders"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Climb Bio (CLYM) disclose for Alexander Cumbo?
Climb Bio disclosed that director Alexander Cumbo received stock options for 40,000 shares of common stock. These options were granted as compensation, not purchased on the open market, and represent a new derivative position reported on the Form 4 filing.
What is the exercise price of Alexander Cumbo’s Climb Bio (CLYM) stock options?
The stock options granted to Alexander Cumbo carry an exercise price of $10.55 per share. This means he can buy Climb Bio common stock at $10.55 once the options vest, regardless of the market price at that time.
When do Alexander Cumbo’s Climb Bio (CLYM) stock options vest?
The options vest on the earlier of June 5, 2027 or the date immediately before the next annual meeting of stockholders. Vesting is conditioned on Cumbo’s continued service with Climb Bio through the applicable vesting date.
How many Climb Bio (CLYM) options does Alexander Cumbo hold after this grant?
Following this transaction, Alexander Cumbo holds 40,000 stock options in Climb Bio. The entire reported position comes from this single grant and represents his derivative holdings as shown in the Form 4 data.
When do Alexander Cumbo’s Climb Bio (CLYM) options expire?
The granted stock options expire on June 4, 2036. After this expiration date, any unexercised options will no longer be usable, so exercise must occur between vesting and that expiration, subject to plan and company policies.
AI-generated analysis. How Rhea-AI works. Not financial advice.
